National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 5) (PB 49 of 2017) (Cth)

PB 49 of 2017

National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 5)

National Health Act 1953

I, LOUISE CLARKE, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated    27   June 2017

LOUISE CLARKE

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 5).

(2)   This Determination may also be cited as PB 49 of 2017.

1. Commencement

This Determination commences on 1 July 2017.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Carmustine

Omit

Cefuroxime

[2]     Schedule 1, after item dealing with Pimecrolimus

Insert

Pirfenidone

[3]     Schedule 1, after item dealing with Vitamins, minerals and trace elements with carbohydrate

Insert

Vorinostat

[4]     Schedule 2, after item dealing with Ceftriaxone

Insert

Cefuroxime